Navigation Links
Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
Date:9/9/2008

- New IVIS Kinetic System Extends Application Breadth of Market-Leading

IVIS Instrument Family -

- Imaging Products Continue to Drive Revenue Growth -

HOPKINTON, Mass., Sept. 9 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS(R) Kinetic preclinical in vivo imaging system. The system enables researchers to non-invasively view biological events at the molecular level as they occur in real-time. The IVIS Kinetic system utilizes the latest developments in ultra-high sensitivity scientific cameras to add video capability to the company's existing line of preclinical, high sensitivity bioluminescence and fluorescence molecular optical imaging offerings. This additional capability will further advance cardiovascular, neurology, immunology and oncology distribution studies conducted using in vivo imaging.

With the launch of the IVIS Kinetic system, researchers are now able to visualize, track, quantify and understand biological processes in real time-as the action happens-driving visual exploration and analysis of gene expression, cellular pathways and drug response. The IVIS Kinetic system features an isolation chamber that allows users to monitor conscious mice freely walking and performing tasks. By capturing images and live video, at the molecular level, researchers can witness dynamic processes and reactions, enhancing the understanding of a drug candidate's potential performance in clinical studies. Specifically, by allowing researchers to view the real-time distribution of drugs and an animal model's responses to a compound, a more thorough understanding of a drug's potential can be assessed.

"The IVIS Kinetic imaging system provides a window for scientists to view biological events as they happen," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "This system is another great example of how Caliper Life Sciences is helping pharma and biotech companies understand complex biological processes to accelerate the discovery of successful drug candidates."

Caliper's IVIS imaging systems have played a significant role in demonstrating the efficacy of various drugs, including Sutent(R) (Pfizer), Sprycel(R) (dasatinib) (Bristol-Myers Squibb), Tasigna(R) (Novartis), and Cubicin(R) (Cubist Pharmaceuticals).

Caliper offers a broad portfolio of imaging systems. For additional information or to order the IVIS Kinetic, please visit: http://www.caliperls.com/products/optical-imaging/.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Caliper and IVIS are registered trademarks of Caliper Life Sciences, Inc. Sutent is a registered trademark of Pfizer, Inc. Sprycel(R) is a registered trademark of Bristol-Myers Squibb. Tasigna is a registered trademark of Novartis. Cubicin is a registered trademark of Cubist Pharmaceuticals.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
8. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference
9. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
10. Caliper Life Sciences to Present at Deutsche Bank 2008 Small and Mid Cap Growth Conference
11. Caliper Life Sciences Fourth Quarter 2007 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 Infectex Ltd., a Russian portfolio company of Maxwell ... of SQ109 added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary ... Inc. ( USA ) and the US National Institutes of Health. ... ... Venture Fund Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research ... customizable vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video ... ways of treating coronary artery disease (CAD). Lam is an assistant professor at ...
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... LEXINGTON, Mass. , March 24, 2017 ... pipeline of immune checkpoint antibodies and cancer vaccines, today ... The 7 th  Annual William Blair and Maidstone ... Event Space Alexandria Center in New York, ... March 29 at 9:40 am: ...
Breaking Biology Technology:
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
(Date:3/1/2017)... 1, 2017  Aware, Inc. (NASDAQ: AWRE), a leading ... Richard P. Moberg has resigned, effective March 3, ... Financial Officer and Treasurer of Aware citing a desire ... a member of the Board of Directors of Aware. ... Executive Officer and co-President, General Counsel has been named ...
Breaking Biology News(10 mins):